Hunt, Penny J.

Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Cawood, T. J., Hunt, P. J., O'Shea, D., Cole, D., & Soule, S. (2009) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 300

Mortality and morbidity in Cushing's syndrome in New Zealand

Bolland, M. J., Holdaway, I. M., Berkeley, J. E., Lim, S., Dransfield, W. J., Conaglen, J. V., Croxson, M. S., Gamble, G. D., Hunt, P. J., & Toomath, R. J. (2011) · Clinical Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 182

Management of hypertension and heart failure in patients with Addison's disease

Inder, W. J., Meyer, C., & Hunt, P. J. (2015) · Clinical Endocrinology

Hormonal Regulation and HypertensionAdrenal Hormones and Disorders

Cited by 20

Three-year follow up of adrenal incidentalomas in a New Zealand centre

Goh, Z., Phillips, I., Hunt, P. J., Soule, S., & Cawood, T. J. (2020) · Internal Medicine Journal

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 14